 |
Previous Article | Next Article 
The Journal of Neuroscience, August 15, 1998, 18(16):6528-6538
Opposite Change of In Vivo Dopamine Release in the
Rat Nucleus Accumbens and Striatum That Follows Electrical Stimulation
of Dorsal Raphe Nucleus: Role of 5-HT3 Receptors
Philippe
De Deurwaerdère1,
Luis
Stinus2, and
Umberto
Spampinato1
1 Institut National de la Santé et de la
Recherche Médicale Unité 259 and 2 Laboratoire
Neuropsychobiologie des Désadaptations, Unité Mixte de
Recherche-Centre National de la Recherche Scientifique 5541, Université Victor Ségalen Bordeaux 2, 33077 Bordeaux Cedex,
France
In the present study we investigate, using in vivo
microdialysis, the involvement of central 5-HT3 receptors
in the effect of dorsal raphe nucleus (DRN) electrical stimulation on
dopamine (DA), 3,4-dihydroxyphenylacetic acid (DOPAC), and
5-hydroxyindole-3-acetic acid (5-HIAA) extracellular levels monitored
in the nucleus accumbens and the striatum of halothane-anesthetized
rats. DRN stimulation (300 µA, 1 msec at 3, 5, 10, and 20 Hz for 15 min) induced a frequency-dependent increase of accumbal DA release and
a concomitant reduction of DA release in the ipsilateral striatum at 20 Hz. In both structures DOPAC and 5-HIAA dialysate contents were
enhanced in a frequency-dependent manner. Central serotonin (5-HT)
depletion, induced by intra-raphe injections of 5,7-dihydroxytryptamine
neurotoxin, abolished the effect of 20 Hz DRN stimulation on DA, DOPAC,
and 5-HIAA extracellular levels in both regions. The 5-HT synthesis
inhibitor para-chlorophenylalanine (3 × 400 mg/kg,
i.p., for 3 d), although preventing the effect on DA release,
failed to modify significantly the effect of 20 Hz DRN stimulation on
DOPAC and 5-HIAA outflow in both structures. Ondansetron (0.1 and 1 mg/kg) and (S)-zacopride (0.1 mg/kg), two 5-HT3 antagonists, significantly impaired the increase of
accumbal DA release induced by 20 Hz DRN stimulation but did not affect either the decrease of striatal DA release or the increase in DOPAC
outflow in both structures. These results indicate that an enhancement
of central 5-HT transmission induced by DRN stimulation differentially
affects striatal and accumbal DA release and that endogenous 5-HT, via
its action on 5-HT3 receptors, exerts a facilitatory control restricted to the mesoaccumbal DA pathway.
Key words:
microdialysis; nucleus accumbens; striatum; dopamine
release; dorsal raphe nucleus; electrical stimulation; serotonin; 5-HT3 receptors; 5,7-dihydroxytryptamine; para-chlorophenylalanine; halothane-anesthetized rat
Copyright © 1998 Society for Neuroscience 0270-6474/98/18166528-11$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
S. Doly, E. Valjent, V. Setola, J. Callebert, D. Herve, J.-M. Launay, and L. Maroteaux
Serotonin 5-HT2B Receptors Are Required for 3,4-Methylenedioxymethamphetamine-Induced Hyperlocomotion and 5-HT Release In Vivo and In Vitro
J. Neurosci.,
March 12, 2008;
28(11):
2933 - 2940.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. B. Fink and M. Gothert
5-HT Receptor Regulation of Neurotransmitter Release
Pharmacol. Rev.,
December 1, 2007;
59(4):
360 - 417.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Zhang, N. A. White, F. S. Soti, W. R. Kem, and T. K. Machu
N-Terminal Domains in Mouse and Human 5-Hydroxytryptamine3A Receptors Confer Partial Agonist and Antagonist Properties to Benzylidene Analogs of Anabaseine
J. Pharmacol. Exp. Ther.,
June 1, 2006;
317(3):
1276 - 1284.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. V. Puig, N. Santana, P. Celada, G. Mengod, and F. Artigas
In Vivo Excitation of GABA Interneurons in the Medial Prefrontal Cortex through 5-HT3 Receptors
Cereb Cortex,
December 1, 2004;
14(12):
1365 - 1375.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. De Deurwaerdere, S. Navailles, K. A Berg, W. P. Clarke, and U. Spampinato
Constitutive Activity of the Serotonin2C Receptor Inhibits In Vivo Dopamine Release in the Rat Striatum and Nucleus Accumbens
J. Neurosci.,
March 31, 2004;
24(13):
3235 - 3241.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Millan, F. Lejeune, and A. Gobert
Reciprocal autoreceptor and heteroreceptor control of serotonergic, dopaminergic and noradrenergic transmission in the frontal cortex: relevance to the actions of antidepressant agents
J Psychopharmacol,
March 1, 2000;
14(2):
114 - 138.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Brown and M. E. Molliver
Dual Serotonin (5-HT) Projections to the Nucleus Accumbens Core and Shell: Relation of the 5-HT Transporter to Amphetamine-Induced Neurotoxicity
J. Neurosci.,
March 1, 2000;
20(5):
1952 - 1963.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Ichikawa and H. Y. Meltzer
R(+)-8-OH-DPAT, a Serotonin1A Receptor Agonist, Potentiated S(-)-Sulpiride-Induced Dopamine Release in Rat Medial Prefrontal Cortex and Nucleus Accumbens But Not Striatum
J. Pharmacol. Exp. Ther.,
December 1, 1999;
291(3):
1227 - 1232.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
N. R. Zahniser, G. A. Larson, and G. A. Gerhardt
In Vivo Dopamine Clearance Rate in Rat Striatum: Regulation by Extracellular Dopamine Concentration and Dopamine Transporter Inhibitors
J. Pharmacol. Exp. Ther.,
April 1, 1999;
289(1):
266 - 277.
[Abstract]
[Full Text]
|
 |
|
|